Literature DB >> 29086124

Lymphocyte-to-monocyte ratio on day 7 is associated with outcomes in acute ischemic stroke.

Min-Gyu Park1, Min-Kyeung Kim1, Song-Hwa Chae1, Hyung-Keun Kim1, Junhee Han2, Kyung-Pil Park3.   

Abstract

The main features of stroke-induced immunosuppression are lymphopenia and deactivation of monocytes in peripheral blood. We hypothesized that lymphocyte-to-monocyte ratio (LMR) in peripheral blood may represent the degree of stroke-induced immunosuppression. To prove this hypothesis, we evaluated whether LMR is associated with risk of post-stroke infection and clinical outcome at 3 months in patients with acute ischemic stroke. We selected patients with stroke in anterior circulation within 24 h from onset. Peripheral blood sampling for differential blood count was performed on days 1 and 7. The LMRs on days 1 and 7 were analyzed to determine associations with excellent outcomes (modified Rankin Scale of score 0-1 at 3 months). One hundred and two patients were included. The initial National Institutes of Health Stroke Scale score (adjusted odd ratio [OR] 0.89; 95% confidence interval [CI], 0.83-0.95; P = 0.001) and LMR on day 7 (adjusted OR 1.49; 95% CI, 1.09-2.02; P = 0.011) were associated with excellent outcomes. LMRs on day 1 were significantly lower in stroke patients with pneumonia (P = 0.007) and pneumonia or urinary tract infection (P = 0.012) than those without infections. LMRs on day 7 were also significantly lower in stroke patients with infection (P = 0.005 in pneumonia, P = 0.003 in urinary tract infection, and P < 0.001 in pneumonia or urinary tract infection) than those without infections. Lower LMRs on day 7 are associated with worse outcomes at 3 months after stroke onset. LMR may be a useful marker for assessing the stroke-induced immunosuppression.

Entities:  

Keywords:  Cerebral infarction; Immunosuppression; Lymphocytes; Monocytes; Stroke

Mesh:

Year:  2017        PMID: 29086124     DOI: 10.1007/s10072-017-3163-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  30 in total

Review 1.  Stroke and the immune system: from pathophysiology to new therapeutic strategies.

Authors:  Richard Macrez; Carine Ali; Olivier Toutirais; Brigitte Le Mauff; Gilles Defer; Ulrich Dirnagl; Denis Vivien
Journal:  Lancet Neurol       Date:  2011-05       Impact factor: 44.182

Review 2.  Modulation of the postischemic immune response to improve stroke outcome.

Authors:  Kyra J Becker
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

Review 3.  Functional role of regulatory lymphocytes in stroke: facts and controversies.

Authors:  Arthur Liesz; Xiaoming Hu; Christoph Kleinschnitz; Halina Offner
Journal:  Stroke       Date:  2015-03-19       Impact factor: 7.914

4.  Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging.

Authors:  P A Barber; M D Hill; M Eliasziw; A M Demchuk; J H W Pexman; M E Hudon; A Tomanek; R Frayne; A M Buchan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11       Impact factor: 10.154

5.  Pneumonia in acute stroke patients fed by nasogastric tube.

Authors:  R Dziewas; M Ritter; M Schilling; C Konrad; S Oelenberg; D G Nabavi; F Stögbauer; E B Ringelstein; P Lüdemann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

6.  Is neutrophil/lymphocyte ratio predict to short-term mortality in acute cerebral infarct independently from infarct volume?

Authors:  Serhat Tokgoz; Suat Keskin; Mehmet Kayrak; Abdullah Seyithanoglu; Aysegul Ogmegul
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-08-06       Impact factor: 2.136

7.  Neutrophil-to-Lymphocyte Ratio Is a Prognostic Marker in Acute Ischemic Stroke.

Authors:  Jie Xue; Wensi Huang; Xiaoli Chen; Qian Li; Zhengyi Cai; Tieer Yu; Bei Shao
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-12-09       Impact factor: 2.136

8.  Neutrophil-to-Lymphocyte Ratio and 30-Day Mortality in Patients with Acute Intracerebral Hemorrhage.

Authors:  Fei Wang; Shanyou Hu; Yong Ding; Xuefeng Ju; Li Wang; Qiuxia Lu; Xiao Wu
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-10-23       Impact factor: 2.136

9.  DAMP signaling is a key pathway inducing immune modulation after brain injury.

Authors:  Arthur Liesz; Alexander Dalpke; Eva Mracsko; Daniel J Antoine; Stefan Roth; Wei Zhou; Huan Yang; Shin-Young Na; Mustafa Akhisaroglu; Thomas Fleming; Tatjana Eigenbrod; Peter P Nawroth; Kevin J Tracey; Roland Veltkamp
Journal:  J Neurosci       Date:  2015-01-14       Impact factor: 6.167

10.  Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation.

Authors:  Konstantin Prass; Christian Meisel; Conny Höflich; Johann Braun; Elke Halle; Tilo Wolf; Karsten Ruscher; Ilya V Victorov; Josef Priller; Ulrich Dirnagl; Hans-Dieter Volk; Andreas Meisel
Journal:  J Exp Med       Date:  2003-08-25       Impact factor: 14.307

View more
  15 in total

1.  Peripheral Monocyte Count Predicts Outcomes in Patients with Acute Ischemic Stroke Treated with rtPA Thrombolysis.

Authors:  Xiaoyu Dong; Jianfei Nao; Yan Gao
Journal:  Neurotox Res       Date:  2019-09-02       Impact factor: 3.911

2.  Peripheral Th17/Treg imbalance in elderly patients with ischemic stroke.

Authors:  Sanam Dolati; Majid Ahmadi; Mohammad Khalili; Ali Akabar Taheraghdam; Homayoon Siahmansouri; Zohreh Babaloo; Leili Aghebati-Maleki; Farhad Jadidi-Niaragh; Vahid Younesi; Mehdi Yousefi
Journal:  Neurol Sci       Date:  2018-01-20       Impact factor: 3.307

3.  Monocyte-based inflammatory indices predict outcomes following aneurysmal subarachnoid hemorrhage.

Authors:  James Feghali; Jennifer Kim; Abhishek Gami; Sarah Rapaport; Justin M Caplan; Cameron G McDougall; Judy Huang; Rafael J Tamargo; Christopher M Jackson
Journal:  Neurosurg Rev       Date:  2021-04-10       Impact factor: 3.042

4.  The clinical influence of the preoperative lymphocyte-to-monocyte ratio on the postoperative outcome of patients with early-stage gastrointestinal cancer.

Authors:  Takayuki Shimizu; Mitsuru Ishizuka; Takayuki Shiraki; Yuhki Sakuraoka; Shozo Mori; Akihito Abe; Yukihiro Iso; Kazutoshi Takagi; Taku Aoki; Keiichi Kubota
Journal:  Ann Gastroenterol Surg       Date:  2020-07-08

Review 5.  Immune Cells After Ischemic Stroke Onset: Roles, Migration, and Target Intervention.

Authors:  Lu-Yao Ao; Yun-Yi Yan; Lin Zhou; Cheng-Yuan Li; Wan-Ting Li; Wei-Rong Fang; Yun-Man Li
Journal:  J Mol Neurosci       Date:  2018-10-01       Impact factor: 3.444

6.  Evaluation of monocyte-to-high-density lipoprotein cholesterol ratio and monocyte-to-lymphocyte ratio in ischemic stroke.

Authors:  Huiling Liu; Feng Zhan; Yazhou Wang
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

7.  The association of neutrophil-lymphocyte ratio and lymphocyte-monocyte ratio with 3-month clinical outcome after mechanical thrombectomy following stroke.

Authors:  Danielle Lux; Vafa Alakbarzade; Luke Bridge; Camilla N Clark; Brian Clarke; Liqun Zhang; Usman Khan; Anthony C Pereira
Journal:  J Neuroinflammation       Date:  2020-02-18       Impact factor: 8.322

8.  Lower lymphocyte to monocyte ratio is a potential predictor of poor outcome in patients with cerebral venous sinus thrombosis.

Authors:  Shen Li; Kai Liu; Rui Zhang; Yuan Gao; Hui Fang; Xinjing Liu; Lulu Pei; L-Ying Richard Chou; Sheng Guan; Xinbin Guo; Haowen Xu; Bo Song; Yuming Xu
Journal:  Stroke Vasc Neurol       Date:  2018-12-04

9.  Chocolate Consumers and Lymphocyte-to-Monocyte Ratio: A Working Hypothesis from a Preliminary Report of a Pilot Study in Celiac Subjects.

Authors:  Anna Raguzzini; Giovanna Poce; Sara Consalvi; Elisabetta Toti; Francesca Palmacci; Mariangela Biava; Ilaria Peluso
Journal:  Antioxidants (Basel)       Date:  2019-10-01

10.  Early neurological deterioration in cardiogenic cerebral embolism due to nonvalvular atrial fibrillation: Predisposing factors and clinical implications.

Authors:  Lin Cong; Weining Ma
Journal:  Brain Behav       Date:  2020-12-04       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.